Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Research and development spending
3Y CAGR
+43.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.44M | +9.0% |
| 2024 | $2.24M | +42.0% |
| 2023 | $1.57M | +88.9% |
| 2022 | $833206.00 | +558.7% |
| 2021 | $126492.00 | - |